Procaps Group S.A. (NASDAQ:PROC – Get Free Report) shares dropped 37.3% during mid-day trading on Tuesday . The stock traded as low as $0.95 and last traded at $0.97. Approximately 100,299 shares were traded during trading, an increase of 690% from the average daily volume of 12,704 shares. The stock had previously closed at $1.55.
Procaps Group Price Performance
The firm has a market cap of $109.44 million, a PE ratio of 1.87 and a beta of 0.17. The company’s 50 day moving average price is $1.91 and its 200 day moving average price is $2.27.
About Procaps Group
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
See Also
- Five stocks we like better than Procaps Group
- Buy P&G Now, Before It Sets A New All-Time High
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is the S&P/TSX Index?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
